retatrutide combination therapy + Cagrilintide – VAYN Substack Series 3 of 6:

The company plans to submit it to the FDA in Q1 2027

This $99 add-on (after your first treatment month) reveals whether you'll respond best to lower maintenance doses, require higher doses, or might benefit from dual-compound therapy like GLP-Squared, personalizing your long-term strategy

This osmotic laxative pulls water into the colon to keep things moving naturally without adding dangerous bulk

We attempt to provide access to educational information about medical conditions and treatment options with minimum interruption

adults with the same age and gender distribution who consider themselves overweight but are not using a GLP-1 medication)